Results 51 to 60 of about 181,335 (186)

Exploration of Hypoglycemic Activity of Saccharomyces pastorianus Extract and Evaluation of the Molecular Mechanisms

open access: yesMolecules, 2021
Although the hypoglycemic potential of brewer’s yeast extract has been reported, there is limited information pertaining to the hypoglycemic ingredients of Saccharomyces pastorianus extract and their mechanisms of action available.
Chien-Hui Wu   +4 more
doaj   +1 more source

Figure 3: KLF Isoforms That Control Metabolism in Skeletal Muscles

open access: yes, 2019
Summary of KLF isoforms and metabolic pathways involved in skeletal muscle biology. A detailed description of the pathways involved in included in the text. Figure was produced using Servier Medical Art (http://www.servier.com/).
Matthew Hoffman (5916764)   +3 more
core   +1 more source

Effects of the sodium–glucose co-transporter 2 inhibitor dapagliflozin in patients with type 2 diabetes and Stages 3b–4 chronic kidney disease [PDF]

open access: yesNephrology Dialysis Transplantation, 2018
The sodium-glucose co-transporter 2 inhibitor dapagliflozin decreases haemoglobin A1c (HbA1c), body weight, blood pressure (BP) and urinary albumin:creatinine ratio (UACR) in patients with type 2 diabetes. The efficacy and safety of this drug have not been properly defined in patients with type 2 diabetes and Stages 3b-4 chronic kidney disease (CKD).In
Dekkers, CCJ   +5 more
openaire   +6 more sources

A cell-based fluorescent glucose transporter assay for SGLT2 inhibitor discovery

open access: yesActa Pharmaceutica Sinica B, 2013
The sodium/glucose cotransporter 2 (SGLT2) is responsible for the majority of glucose reabsorption in the kidney, and currently, SGLT2 inhibitors are considered as promising hypoglycemic agents for the treatment of type 2 diabetes mellitus.
Yi Huan   +4 more
doaj   +1 more source

Potential for combination of dipeptidyl peptidase‐4 inhibitors and sodium‐glucose co‐transporter‐2 inhibitors for the treatment of type 2 diabetes [PDF]

open access: yesDiabetes, Obesity and Metabolism, 2015
In individuals with advanced type 2 diabetes ( T2DM ), combination therapy is often unavoidable to maintain glycaemic control. Currently metformin is considered the first line of defence, but many patients experience gastrointestinal adverse events, necessitating an alternative treatment ...
openaire   +2 more sources

Visual Abstract - Deletion of Sulfonylurea Receptor 2 in the Adult Myocardium Enhances Cardiac Glucose Uptake and Is Cardioprotective: 10.1016/j.jacbts.2018.11.012

open access: yes, 2019
• In the heart, SUR2 couples with a potassium channel to form an adenosine triphosphate–sensitive complex that responds to the energy state of the cell.• The authors deleted SUR2 in adult cardiomyocytes and found a shift of the heart toward glycolytic ...
Michele Hadhazy (2697553)   +9 more
core   +1 more source

Regulation of injury-induced skeletal myofiber regeneration by glucose transporter 4 (GLUT4)

open access: yesSkeletal Muscle
Background Insulin resistance and type 2 diabetes impair cellular regeneration in multiple tissues including skeletal muscle. The molecular basis for this impairment is largely unknown.
Tyler J. Sermersheim   +5 more
doaj   +1 more source

Gene expression of selected glycolytic enzymes and glucose transporter in the muscle of rainbow trout from L line (L; grey bars) and F line (F; black bars) at 3 h (A), 8 h (B) and 12 h (C) after IP administration of glucose or saline solution.

open access: yes, 2014
Hexokinase (HK), 6-phosphofructo-1-kinase (6PFK), pyruvate kinase (PK) and glucose transporter type 4 (GLUT4) mRNA levels were measured using real-time quantitative RT-PCR. Expression values were normalized by β-actin-transcripts.
Biju Sam Kamalam (466579)   +5 more
core   +1 more source

Conjugated linoleic acid supplementation enhances insulin sensitivity and peroxisome proliferator-activated receptor gamma and glucose transporter type 4 protein expression in the skeletal muscles of rats during endurance exercise [PDF]

open access: yes, 2016
Objective(s):This study examined whether conjugated linoleic acid (CLA) supplementation affects insulin sensitivity and peroxisome proliferator-activated receptor gamma (PPAR-γ) and glucose transporter type 4 (GLUT-4) protein expressions in the skeletal ...
Youngju Song, Kangok Cho, Daekeun Kwon
core  

Eicosapentaenoic Acid (EPA) Modulates Glucose Metabolism by Targeting AMP-Activated Protein Kinase (AMPK) Pathway

open access: yes, 2019
EPA, an omega-3 polyunsaturated fatty acid, exerts beneficial effects on human health. However, the molecular mechanisms underlying EPA function are poorly understood. The object was to illuminate molecular mechanism underlying EPA’s role. Here, 1H-
Miso Nam   +5 more
core   +2 more sources

Home - About - Disclaimer - Privacy